CTOs on the Move

Celularity

www.celularity.com

 
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and economics. Celularity`s innovative approach to cell therapy harnesses the unique therapeutic potential locked within the postpartum placenta. Through nature`s immunotherapy engine – the placenta – Celularity is leading the next evolution of cellular medicine with placenta-derived T cells, NK cells, and pluripotent stem cells to target unmet and underserved clinical needs in cancer, infectious and degenerative diseases.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Bradley Glover
 Executive Vice President and Chief Technology Officer Profile
Bradley Glover
 Executive Vice President and Chief Operating Officer Profile

Funding

Celularity raised $250M on 02/15/2018

Similar Companies

twoXAR

twoXAR is an artificial intelligence-driven drug discovery company.

Nura Inc

Nura Inc is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

clarient

clarient is a Aliso Viejo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pharmacists Mutual Companies

Pharmacists Mutual Companies is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Pandion Therapeutics

Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.